Cargando…
Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test
Rapid and widespread diagnostic testing is critical to providing timely patient care and reducing transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recently, the Visby Medical COVID-19 point of care (POC) test was granted emergency use authorization (EUA) for qualitative...
Autores principales: | Katzman, Brooke M., Wockenfus, Amy M., Kelley, Brandon R., Karon, Brad S., Donato, Leslie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595255/ https://www.ncbi.nlm.nih.gov/pubmed/34798145 http://dx.doi.org/10.1016/j.clinbiochem.2021.11.007 |
Ejemplares similares
-
Evaluation of the analytical sensitivity of ACON and LumiraDx SARS-CoV-2 rapid antigen tests using samples with presumed Omicron variant
por: Karon, Brad S., et al.
Publicado: (2023) -
Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center
por: Donato, Leslie J., et al.
Publicado: (2021) -
Microfluidic Biosensors for Point-of-Care Nucleic Acid Amplification Tests
por: Trinh, Kieu The Loan
Publicado: (2022) -
Extended opening hours at nightclubs in Visby: An evaluation of a trial in the summer of 2014
por: Norström, Thor, et al.
Publicado: (2018) -
Thermal inactivation and nucleic acid amplification-based testing for SARS-CoV-2
por: Péré, Hélène, et al.
Publicado: (2020)